Earnings History Data for Vericel Corporation (VCEL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vericel Corporation

Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the knee, and Epicel (R) for the treatment of severe burns. It is also developing MACI (TM) for the treatment of cartilage defects in the knee, and ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. Vericel Corporation, formerly Aastrom Biosciences, Inc., is based in United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		VCEL	Vericel Corporation	2,190	-0.02	-0.05	-0.08	Vericel GAAP EPS of -$0.02 beats by $0.03, revenue of $57.91M beats by $2.71M [11/7/2024 8:05 AM]	50.03	1.99 (4.15%)	48.04	0.0 (0.00%)	32.28 - 54.10	441,937	420,000	31,915
Vericel Q3 2024 Earnings Preview [11/6/2024 3:35 PM] Vericel GAAP EPS of -$0.02 beats by $0.03, revenue of $57.91M beats by $2.71M [11/7/2024 8:05 AM] Vericel Reports Third Quarter 2024 Financial Results [2024-11-07 07:55AM] Vericel Corp (VCEL) Q3 2024 Earnings Report Preview: What To Look For [Nov-06-24 07:15AM]
01-08-2024	PM		VCEL	Vericel Corporation	2,490	-0.10	-0.10	-0.11	Vericel GAAP EPS of -$0.10 misses by $0.01, revenue of $52.66M beats by $0.07M [8/1/2024 7:58 AM]	47.57	-2.95 (-5.84%)	50.48	-0.04 (-0.08%)	30.18 - 54.08	1,020,225	300,000	1,702
Vericel Q2 2024 Earnings Preview [7/31/2024 12:06 PM] Vericel GAAP EPS of -$0.10 misses by $0.01, revenue of $52.66M beats by $0.07M [8/1/2024 7:58 AM]
08-05-2024	PM		VCEL	Vericel Corporation	2,270	-0.08	-0.11	-0.16	Vericel GAAP EPS of -$0.08 beats by $0.03, revenue of $51.3M beats by $2.23M [5/8/2024 7:58 AM]	47.69	-1.83 (-3.70%)	47.69	0.0 (0.00%)	30.18 - 53.05	627,685	350,000	20,494
Vericel GAAP EPS of -$0.08 beats by $0.03, revenue of $51.3M beats by $2.23M [5/8/2024 7:58 AM] Vericel Q1 2024 Earnings Preview [5/7/2024 11:43 AM]
29-02-2024	PM		VCEL	Vericel Corporation	2,290	0.26	0.18	0.12	Vericel GAAP EPS of $0.26 beats by $0.09, revenue of $65M beats by $1.05M [2/29/2024 8:00 AM]	45.70	-2.09 (-4.38%)	48.54	0.74 (1.55%)	27.92 - 50.09	744,419	470,000	865
Vericel Q4 2023 Earnings Preview [2/28/2024 10:48 AM] Vericel GAAP EPS of $0.26 beats by $0.09, revenue of $65M beats by $1.05M [2/29/2024 8:00 AM]
08-11-2023	PM		VCEL	Vericel Corporation	1,720	-0.08	-0.13	-0.14	Vericel GAAP EPS of -$0.08 beats by $0.04, revenue of $45.6M beats by $0.45M [11/8/2023 7:57 AM]	35.27	-1.24 (-3.40%)	35.27	0.0 (0.00%)	17.30 - 39.90	402,649	310,000	7,557
Vericel Q3 2023 Earnings Preview [11/7/2023 12:03 PM] Vericel GAAP EPS of -$0.08 beats by $0.04, revenue of $45.6M beats by $0.45M [11/8/2023 7:57 AM]
02-08-2023	PM		VCEL	Vericel Corporation	1,710	-0.11	-0.13	-0.19	Vericel beats Q2 top and bottom line estimates; raises FY23 revenue outlook [8/2/2023 7:58 AM]	34.71	-0.41 (-1.17%)	34.50	-0.62 (-1.77%)	17.30 - 39.90	480,057	390,000	5,023
Vericel Q2 2023 Earnings Preview [8/1/2023 1:23 PM] Vericel beats Q2 top and bottom line estimates; raises FY23 revenue outlook [8/2/2023 7:58 AM]
10-05-2023	PM	7:55 AM ET (May 10)	VCEL	Vericel Corporation	1,570	-0.16	-0.13	-0.15	Vericel GAAP EPS of -$0.16 misses by $0.01, revenue of $41.01M beats by $3.64M [5/10/2023 7:57 AM]	34.25	1.41 (4.29%)	0.0	0.0 (0.00%)	17.30 - 35.46	303,682	280,000	0
Vericel Q1 2023 Earnings Preview [5/9/2023 11:25 AM] Vericel GAAP EPS of -$0.16 misses by $0.01, revenue of $41.01M beats by $3.64M [5/10/2023 7:57 AM]
23-02-2023	PM	7:55 AM ET (Feb 23)	VCEL	Vericel Corporation	1,410	0.12	0.01	0.09	Vericel GAAP EPS of $0.12 beats by $0.08, revenue of $52.69M misses by $0.27M [2/23/2023 7:56 AM]	30.57	2.05 (7.19%)	0.0	0.0 (0.00%)	17.30 - 43.97	467,322	330,000	0
Vericel GAAP EPS of $0.12 beats by $0.08, revenue of $52.69M misses by $0.27M [2/23/2023 7:56 AM]
09-11-2022	PM	7:55 AM ET (Nov 9)	VCEL	Vericel Corporation	1,140	-0.14	-0.12	-0.11	Vericel GAAP reports Q3 earnings miss; narrows FY22 guidance range below estimates [11/9/2022 7:58 AM]	17.84	-5.21 (-22.60%)	22.01	-1.04 (-4.51%)	17.30 - 46.30	1,789,118	440,000	842
Vericel GAAP reports Q3 earnings miss; narrows FY22 guidance range below estimates [11/9/2022 7:58 AM]
03-08-2022	PM	7:55 AM ET (Aug 3)	VCEL	Vericel Corporation	1,330	-0.19	-0.13	-0.08	Vericel GAAP EPS of -$0.19 misses by $0.07, revenue of $37.05M misses by $1.3M [8/3/2022 7:59 AM]	31.65	-0.16 (-0.50%)	31.81	0.0 (0.00%)	22.42 - 60.24	411,677	360,000	5,740
Vericel Q2 2022 Earnings Preview [8/2/2022 2:06 PM] Vericel GAAP EPS of -$0.19 misses by $0.07, revenue of $37.05M misses by $1.3M [8/3/2022 7:59 AM] MediWound refiling for NexoBrid to treat severe thermal burns gets FDA review [8/3/2022 8:22 AM] MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns [Aug-03-22 07:30AM]
04-05-2022	PM	7:55 AM ET (May 4)	VCEL	Vericel	1,339	-0.15	-0.15	0.00	Vericel GAAP EPS of -$0.15 misses by $0.03, revenue of $36.07M beats by $1.76M [5/4/2022 7:58 AM]	31.11	-0.24 (-0.78%)	31.36	0.0 (0.00%)	28.39 - 68.94	556,823	550,000	19,772
Vericel Q1 2022 Earnings Preview [5/3/2022 11:56 AM] Vericel GAAP EPS of -$0.15 misses by $0.03, revenue of $36.07M beats by $1.76M [5/4/2022 7:58 AM] Vericel Reports First Quarter 2022 Financial Results [May-04-22 07:55AM] Vericel Corporation (VCEL) Reports Q1 Loss, Tops Revenue Estimates [May-04-22 09:05AM]
24-02-2022	PM	7:40 AM ET (Feb 24)	VCEL	Vericel Corporation	1,560	0.09	0.17	0.25	Vericel GAAP EPS of $0.09 misses by $0.05, revenue of $47.6M misses by $0.49M; initiates FY22 guidance [2/24/2022 7:58 AM]	38.65	6.47 (20.11%)	0.0	0.0 (0.00%)	30.67 - 68.94	836,214	522,077	0
Vericel Q4 2021 Earnings Preview [2/23/2022 1:59 PM] Vericel GAAP EPS of $0.09 misses by $0.05, revenue of $47.6M misses by $0.49M; initiates FY22 guidance [2/24/2022 7:58 AM] Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance [Feb-24-22 07:55AM] Vericel Corporation (VCEL) Q4 Earnings Miss Estimates [Feb-24-22 09:15AM] Vericel (VCEL) Q4 2021 Earnings Call Transcript [Feb-24-22 06:30PM] Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer [Feb-24-22 04:45PM]
09-11-2021	PM	8:00 AM ET (Nov 9)	VCEL	Vericel Corporation	2,270	-0.11	-0.03	0.08	Vericel EPS misses by $0.08, misses on revenue [11/9/2021 7:46 AM]	42.20	-0.90 (-2.09%)	40.00	-3.10 (-7.19%)	22.93 - 68.94	631,810	340,000	13,796
Vericel Q3 2021 Earnings Preview [11/8/2021 12:26 PM] Vericel EPS misses by $0.08, misses on revenue [11/9/2021 7:46 AM] Vericel Reports Third Quarter 2021 Financial Results [Nov-09-21 07:40AM] Vericel Corporation (VCEL) Reports Q3 Loss, Misses Revenue Estimates [Nov-09-21 08:55AM] Vericel (VCEL) Q3 2021 Earnings Call Transcript [Nov-09-21 08:01PM]
04-08-2021	PM	7:00 AM ET (Aug 4)	VCEL	Vericel Corporation	2,460	-0.08	-0.05	-0.18	Vericel EPS in-line, beats on revenue; raises guidance [8/4/2021 8:10 AM]	49.18	-2.54 (-4.91%)	49.18	0.0 (0.00%)	14.45 - 68.94	873,510	250,000	13,351
Vericel Q2 2021 Earnings Preview [8/3/2021 3:09 PM] Vericel EPS in-line, beats on revenue; raises guidance [8/4/2021 8:10 AM] Vericel Reports Second Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance [Aug-04-21 08:00AM] Vericel Corporation (VCEL) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-21 09:45AM]
05-05-2021	PM	8:00 AM ET (May 5)	VCEL	Vericel Corporation	2,880	-0.07	-0.06	-0.10	Vericel EPS misses by $0.03, beats on revenue [5/5/2021 7:07 AM]	56.59	-2.56 (-4.33%)	56.59	0.0 (0.00%)	12.82 - 64.89	603,157	490,000	5,432
Vericel Q1 2021 Earnings Preview [5/4/2021 2:08 PM] Vericel EPS misses by $0.03, beats on revenue [5/5/2021 7:07 AM] Vericel Corp. to Host Earnings Call [May-05-21 06:45AM] Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance [May-05-21 07:00AM] Vericel Corporation (VCEL) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 08:35AM]
24-02-2021	PM	8:00 AM ET (Feb 24)	VCEL	Vericel Corporation	2,200	0.25	0.21	0.20	Vericel EPS beats by $0.05, beats on revenue [2/24/2021 8:02 AM]	49.38	2.01 (4.24%)	47.37	0.0 (0.00%)	6.78 - 53.98	426,982	713,367	697
Vericel EPS beats by $0.05, beats on revenue [2/24/2021 8:02 AM] Vericel Q4 2020 Earnings Preview [2/23/2021 11:24 AM] Vericel (VCEL) Q4 2020 Earnings Call Transcript [Feb-24-21 02:01PM] Vericel Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Full-Year 2021 Financial Guidance [Feb-24-21 08:00AM]
05-11-2020	PM	8:00 AM ET (Nov 5)	VCEL	Vericel Corporation	946.64	0.08	-0.03	0.07	Vericel EPS beats by $0.10, beats on revenue [11/5/2020 8:03 AM]	21.73	0.53 (2.50%)	21.73	0.0 (0.00%)	6.78 - 22.26	682,722	404,134	7,413

05-08-2020	PM	8:00 AM ET (Aug 5)	VCEL	Vericel Corporation	743.87	-0.18	-0.23	-0.05	Vericel EPS beats by $0.02, beats on revenue [8/5/2020 8:07 AM]	16.10	-0.72 (-4.28%)	16.82	0.0 (0.00%)	6.78 - 19.77	284,161	468,252	8,508

05-05-2020	PM	8:00 AM ET (May 5)	VCEL	Vericel Corporation	629.69	-0.10	-0.09	-0.07	Vericel EPS misses by $0.02, beats on revenue [5/5/2020 8:02 AM]	14.77	0.75 (5.35%)	14.25	0.23 (1.64%)	6.78 - 19.95	203,683	856,193	207